Pharmacogenetics aspects of oral anticoagulants therapy

Journal of medicine and life

Volumn 8, Issue 2, 2015, Pages 171-175

  Militaru, F C ^a   Vesa, S C ^a   Pop, T R ^a   Buzoianu, A D ^a  

^a University of Medicine and Pharmacy Iuliu Ha ieganu Cluj Napoca   (Romania)

Author keywords

CYP2C9 gene; Vitamin K antagonists; VKORC1 gene

Indexed keywords

ANTICOAGULANT AGENT; CYTOCHROME P450 2C9; VITAMIN K EPOXIDE REDUCTASE; VITAMIN K GROUP; VKORC1 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; GENETICS; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOGENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CYTOCHROME P-450 CYP2C9; HUMANS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMIN K; VITAMIN K EPOXIDE REDUCTASES;

EID: 85018214581     PISSN: None     EISSN: 18443117     Source Type: Journal    
DOI: None     Document Type: Article

References (0)